| 1SEQ | L:107-211 | FAB MNAC13 |
| 1T2Q | L:115-218 | THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN |
| 1UYW | L:108-212; N:108-211 | CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2 |
| 1WC7 | A:108-214; L:108-213 | FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE |
| 1WCB | A:108-214; L:108-214 | PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN |
| 1XGP | A:108-214 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1XGQ | A:108-214 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1XGR | A:108-214 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1XGT | A:108-214 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1YJD | L:108-212 | CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1) |
| 1YNT | A:108-213; C:1108-1213 | STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY |
| 1YQV | L:108-212 | THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION |
| 1ZTX | L:108-212 | WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB |
| 2A6J | A:108-214; L:108-214 | CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 |
| 2ADF | L:107-209 | CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3, AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN |
| 2ADG | A:108-211 | CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 |
| 2ADI | A:108-211 | CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM |
| 2ADJ | A:108-211 | CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM |
| 2AJS | L:108-211 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL |
| 2AJU | L:108-211 | CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' |
| 2AJV | L:108-211 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE |
| 2AJX | L:108-211 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG |
| 2AJY | L:108-211 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID |
| 2AJZ | A:108-211; L:108-211 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER |
| 2AK1 | L:108-211 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID |
| 2B2X | L:115-215; M:115-215 | VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB |
| 2BMK | A:108-214; L:108-214 | FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE |
| 2BOC | B:108-212 | POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS) |
| 2C1P | A:108-213; L:108-213 | FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE |
| 2DDQ | L:113-218 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT |
| 2DQT | L:108-214 | HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG |
| 2DQU | L:108-214 | CRYSTAL FORM II: HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 6D9 AND A TRANSITION-STATE ANALOG |
| 2DTM | L:108-213 | THERMODYNAMIC AND STRUCTURAL ANALYSES OF HYDROLYTIC MECHANISM BY CATALYTIC ANTIBODIES |
| 2EH7 | L:108-214 | CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB |
| 2EXY | D:107-211; F:107-211 | CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS |
| 2FAT | L:107-213 | AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE |
| 2FSE | B:93-190; D:93-189 | CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN |
| 2G2R | A:108-214; L:108-214 | GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE) |
| 2GCY | A:111-216 | HUMANIZED ANTIBODY C25 FAB FRAGMENT |
| 2H2P | D:107-211; F:107-211 | CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN- |
| 2H2S | D:107-211; F:107-211 | CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN- |
| 2HKH | L:113-219 | CRYSTAL STRUCTURE OF THE FAB M75 |
| 2I9L | A:113-219; C:113-219; E:113-219; G:113-219 | STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN |
| 2IPT | L:107-213 | PFA1 FAB FRAGMENT |
| 2IQ9 | L:107-213 | PFA2 FAB FRAGMENT, TRICLINIC APO FORM |
| 2IQA | A:107-213; L:107-213 | PFA2 FAB FRAGMENT, MONOCLINIC APO FORM |
| 2J4W | L:108-214 | STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX |
| 2J5L | B:108-214 | STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX |
| 2NR6 | C:108-211; E:108-211 | CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2 |
| 2NTF | A:109-211; L:109-211 | CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N-ACYL-L-HOMOSERINE LACTONE ANALOG |
| 2OP4 | L:109-212 | CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9 |
| 2ORB | L:108-212; M:108-213 | THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT |
| 2OZ4 | L:108-214 | STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION |
| 2Q8A | L:108-214 | STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY |
| 2Q8B | L:108-213 | STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY |
| 2R0W | L:107-213 | PFA2 FAB COMPLEXED WITH ABETA1-8 |
| 2R0Z | L:107-213 | PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT |
| 2R29 | L:112-213 | NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY |
| 2R9H | D:107-211; F:107-211 | CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB |
| 2UYL | A:113-218; M:113-216; V:113-216; X:113-216 | CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1 |
| 2V17 | L:108-214 | STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN |
| 2V7H | A:108-214; L:108-214 | CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT |
| 2VC2 | L:108-214 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758 |
| 2VDK | L:108-214 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE |
| 2VDL | L:108-214 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE |
| 2VDM | L:108-214 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN |
| 2VDN | L:108-214 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE |
| 2VL5 | B:112-217; D:112-216 | STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1 |
| 2VQ1 | A:108-212; E:108-212 | ANTI TRIMERIC LEWIS X FAB54-5C10-A |
| 2VXT | L:108-213 | CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB |
| 2VXU | L:108-214; M:108-214 | CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT |
| 2W60 | B:113-217 | ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 |
| 2W9D | L:107-211 | STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY AT 1.57 A RESOLUTION. |
| 2W9E | L:110-212 | STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231 |
| 2XKN | A:108-213; C:108-213 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7 |
| 2XQY | K:108-214; L:108-214 | CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3 |
| 2YPV | L:108-212 | CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY |
| 2Z4Q | A:113-219 | CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528 |
| 2Z91 | B:108-212; D:108-213 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 |
| 2Z92 | B:108-211 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE |
| 2ZCH | L:108-211 | CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY |
| 3ARB | C:118-207; D:119-247 | TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH |
| 3ARD | C:118-207 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA-GALACTOSYLCERAMIDE |
| 3ARE | C:118-207; D:119-247 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE |
| 3ARF | C:118-207; D:119-247 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2 |
| 3ARG | C:118-207 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA-GLUCOSYLCERAMIDE(C20:2) |
| 3AU1 | A:186-279 | CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3 |
| 3AXL | A:130-218; B:130-256; G:130-218; H:130-256 | MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR |
| 3BGF | C:108-211; L:108-212 | X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB |
| 3BT2 | L:107-212 | STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX |
| 3BZ4 | A:108-211; C:108-213; E:108-211; G:108-211 | CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE |
| 3C5S | A:108-213; C:108-212 | CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG |
| 3C5Z | A:113-202; B:113-240; E:113-201; F:113-240 | CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506 |
| 3C60 | A:112-201; B:112-236; E:112-201; F:112-236 | CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62 |
| 3C6S | A:108-211; C:108-213; E:108-211; G:108-211 | CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE |
| 3CFB | A:108-213; L:108-213 | HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K |
| 3CFC | L:108-214 | HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 |
| 3CFD | A:108-213; L:108-213 | PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN |
| 3CFE | A:108-213; L:108-213 | CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10 |
| 3CLE | L:108-212 | HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 |
| 3CLF | L:108-214 | HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 |
| 3CMO | L:108-211; X:108-211 | HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18 |
| 3CVH | L:107-209; R:107-209 | HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE |
| 3CVI | L:107-209 | HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE |
| 3D9A | L:108-213 | HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME |
| 3E8U | L:108-212 | CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION |
| 3EFD | L:108-211 | THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA |
| 3EO0 | A:109-215; C:109-215 | STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008 |
| 3EO1 | A:108-215; D:108-215; G:108-215; J:108-215 | STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3 |
| 3EOT | L:112-214 | CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB |
| 3FB6 | B:108-212 | KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112 |
| 3FO9 | A:108-214; L:108-214 | CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB' IN COMPLEX WITH HAPTEN 1,3-DIKETONE |
| 3G08 | A:186-279 | CRYSTAL STRUCTURE OF THE ALPHA-GALACTOSYLCERAMIDE ANALOG OCH IN COMPLEX WITH MOUSE CD1D |
| 3G5X | A:108-214; C:108-214 | ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR |
| 3G5Z | A:111-213 | ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR |
| 3GI8 | L:114-220 | CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT |
| 3GI9 | L:114-219 | CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT |
| 3GNM | L:113-217 | THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT |
| 3HE6 | C:118-208; D:119-247 | CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR |
| 3HE7 | C:118-207 | CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR |
| 3HKF | A:241-344; A:345-445 | MURINE UNGLYCOSYLATED IGG FC FRAGMENT |
| 3HNS | L:108-214 | CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE |
| 3HNT | L:108-214 | CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN |
| 3HNV | L:108-214 | CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE) |
| 3HZK | A:107-212 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO |
| 3HZM | A:107-212 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO |
| 3HZV | A:107-212 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO |
| 3HZY | A:107-210 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO |
| 3I02 | A:107-213; C:107-207 | CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO |
| 3I2C | L:112-218 | CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088 |
| 3I50 | L:108-208 | CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB |
| 3I75 | A:108-212 | ANTIBODY STRUCTURE |
| 3I9G | L:108-213 | CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE |
| 3IET | A:108-212; C:108-213 | CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN |
| 3IJH | A:107-212; C:107-212 | STRUCTURE OF S67-27 IN COMPLEX WITH KO |
| 3IJS | A:107-212; C:107-211 | STRUCTURE OF S67-27 IN COMPLEX WITH TSBP |
| 3IJY | A:107-210; C:107-212 | STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO |
| 3IKC | A:107-212; C:107-212 | STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO |
| 3ILP | A:186-279 | STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2F FROM BORRELIA BURGDORFERI |
| 3ILQ | C:186-279 | STRUCTURE OF MCD1D WITH BOUND GLYCOLIPID BBGL-2C FROM BORRELIA BURGDORFERI |
| 3IU4 | L:108-213 | ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3 |
| 3IVK | B:109-213; L:109-213 | CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT |
| 3IXT | B:108-211; L:108-212 | CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE |
| 3KJ4 | B:113-219; L:113-219 | STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY |
| 3L1O | L:108-214 | CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC |
| 3L5W | A:108-213; L:108-213 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB |
| 3L7E | A:108-213; L:108-213 | CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836 |
| 3LIZ | L:108-211 | CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3 |
| 3LS4 | L:109-215 | CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC |
| 3LS5 | L:109-215 | ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM |
| 3MA7 | A:186-279; C:186-279 | CRYSTAL STRUCTURE OF CARDIOLIPIN BOUND TO MOUSE CD1D |
| 3MBX | L:114-220 | CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836 |
| 3MCK | A:113-219; L:113-219 | CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705 |
| 3MCL | L:106-209 | ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21 |
| 3MXV | L:108-212 | CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA |
| 3NID | F:108-214; L:108-214 | THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING |
| 3NIF | F:108-214; L:108-214 | THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING |
| 3NIG | F:108-214; L:108-214 | THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING |
| 3NZ8 | B:108-212; L:108-213 | CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8 |
| 3O0R | L:108-213 | CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT |
| 3O11 | A:106-212; L:106-212 | ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2 |
| 3O2D | L:107-210 | CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY |
| 3O6K | L:113-217 | CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1 |
| 3O8X | A:186-279; C:118-206; D:113-240 | RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR |
| 3O9W | A:186-279; C:118-206; D:113-240 | RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR |
| 3OJD | A:108-214 | ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT) |
| 3OKD | A:108-214 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO |
| 3OKE | A:108-212 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO |
| 3OKK | A:108-215 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO |
| 3OKL | A:108-214 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO |
| 3OKM | A:108-214 | CRYSTAL STRUCTURE OF UNLIGANDED S25-39 |
| 3OKN | A:108-213 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO |
| 3OKO | A:108-212 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO |
| 3OZ9 | L:111-213 | CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1 |
| 3PHO | A:111-217 | CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP |
| 3PHQ | A:111-217 | CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO |
| 3PP3 | K:113-219; L:113-219 | EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES |
| 3Q3G | A:114-220; C:114-220; F:114-220; J:114-220 | CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY |
| 3Q5T | A:116-240 | V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES |
| 3Q5Y | A:118-247; B:118-246; C:118-247; D:118-246 | V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES |
| 3QA3 | A:121-220; C:121-220; F:121-220; J:121-220 | CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY |
| 3QG7 | L:108-211 | STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY |
| 3QI9 | C:118-204; D:119-243 | CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR |
| 3QIB | A:82-180; B:94-186; D:117-243 | CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK |
| 3QIU | A:82-181; B:93-186; C:110-186; D:117-243 | CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK |
| 3QJF | A:112-201; C:112-199 | CRYSTAL STRUCTURE OF THE 2B4 TCR |
| 3QJH | A:118-206; B:120-247; C:118-206; D:120-246 | THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR |
| 3QUX | A:186-279; C:118-206 | STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX |
| 3QUY | A:186-279; C:118-206 | STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX |
| 3QUZ | A:186-279; C:118-206 | STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX |
| 3QWO | B:108-211; L:108-211 | CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB |
| 3RA7 | L:108-211; M:108-211 | BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY |
| 3RAJ | L:106-208 | CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7 |
| 3RGV | A:111-200; B:113-236 | A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS |
| 3RKD | C:108-213; L:108-213 | HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY |
| 3RTQ | A:186-279 | STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX |
| 3RUG | A:186-296; C:186-295; E:130-218; F:129-256; G:130-218; H:129-256 | CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D-ALPHAGLUCOSYLCERAMIDE (C20:2) |
| 3RVT | C:111-213 | STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP |
| 3RVU | C:111-212 | STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP |
| 3RVV | | [entry was replaced by entry 5VPL without any SCOP domain information] |
| 3RVW | | [entry was replaced by entry 5VPG without any SCOP domain information] |
| 3RVX | | [entry was replaced by entry 5VPH without any SCOP domain information] |
| 3RZC | A:186-279 | STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR |
| 3S34 | L:108-214 | STRUCTURE OF THE 1121B FAB FRAGMENT |
| 3S35 | L:112-217 | STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES |
| 3S37 | L:108-213 | STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES |
| 3SCM | C:118-204; D:119-243 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE |
| 3SDA | A:186-295; C:118-204; D:119-243 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE |
| 3SDC | C:118-204; D:120-243 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE |
| 3SDD | C:118-203; D:120-242 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE |
| 3SGD | I:113-218; L:113-218 | CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2 |
| 3SGE | I:113-219; L:113-219 | CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE |
| 3T1F | A:186-279 | CRYSTAL STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2 COMPLEX |
| 3T3M | F:108-214; L:108-214 | A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS |
| 3T3P | F:108-214; L:108-214 | A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS |
| 3TA3 | A:186-279; C:118-206; D:113-240 | STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX |
| 3TT1 | L:112-215; M:112-215 | CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB |
| 3TVM | A:186-279; C:118-206; D:113-240; E:186-249; G:118-206; H:113-240 | STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX |
| 3U0W | L:108-213 | AD RELATED MURINE ANTIBODY FRAGMENT |
| 3UBX | I:108-214; L:108-214 | CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX |
| 3UJT | L:108-211; M:108-211 | STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O-ANTIGEN OF FRANCISELLA TULARENSIS |
| 3V0V | B:108-212; L:108-212 | FAB WN1 222-5 UNLIGANDED |
| 3V0W | L:108-211 | CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS |
| 3V6F | B:115-219; D:115-219; F:115-219; L:115-219 | CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND |
| 3V6O | E:110-216; F:110-216 | LEPTIN RECEPTOR-ANTIBODY COMPLEX |
| 3VFG | L:108-214 | CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE |
| 3VG0 | L:110-215 | ANTIBODY FAB FRAGMENT |
| 3VG9 | B:108-212 | CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION |
| 3VGA | B:108-212 | CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION |
| 3VI3 | E:113-219; L:113-219 | CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM) |
| 3ZDX | F:108-214; L:108-214 | INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX |
| 3ZKM | D:112-217; L:112-217 | BACE2 FAB COMPLEX |
| 3ZKN | D:112-217; L:112-217 | BACE2 FAB INHIBITOR COMPLEX |
| 4A6Y | L:111-211 | CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3-NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 |
| 4AEH | L:108-212 | CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY |
| 4AEI | L:113-218; M:113-217; N:113-217 | CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX |
| 4AG4 | L:108-212 | CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX |
| 4ALA | L:108-212 | STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12 |
| 4AMK | L:111-212 | FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10 |
| 4APQ | C:120-206 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE |
| 4AT6 | B:111-212; D:111-212; F:111-212; I:111-212; K:111-212; L:111-212; N:111-212; P:111-212 | FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7 |
| 4DGI | L:108-213 | STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120-230 |
| 4DVB | B:109-215; L:109-215 | THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112 |
| 4DW2 | L:108-214 | THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB-112 |
| 4EBQ | L:111-214 | FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5 |
| 4EDX | A:108-214; L:108-214 | NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911 |
| 4EI5 | C:115-202 | CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1 |
| 4EI6 | A:115-203; B:116-243; C:115-202; D:116-243 | STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR |
| 4ELK | A:116-204; B:117-244; C:116-207; D:117-244 | CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR |
| 4ETQ | B:111-213; L:111-213 | VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 |
| 4F15 | C:111-213; F:111-213; I:111-213; L:111-213 | MOLECULAR BASIS OF INFECTIVITY OF 2009 PANDEMIC H1N1 INFLUENZA A VIRUSES |
| 4F2M | B:108-213; D:108-211 | CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10 |
| 4F33 | A:107-212; C:107-212; E:107-212; G:107-212 | CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 |
| 4F37 | K:113-218; L:113-218 | STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER'S DISEASE A PEPTIDE |
| 4F3F | A:107-212 | CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX |
| 4FFV | C:107-210; L:107-210 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB |
| 4FFW | C:107-210; L:107-206 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN |
| 4FG6 | D:107-211; F:107-211 | STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE |
| 4GAY | B:108-212; L:108-211 | STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 |
| 4GMS | L:108-211; N:108-213 | CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ |
| 4GMT | L:108-213; M:108-213 | CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 |
| 4GQ9 | L:110-212 | CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT |
| 4H20 | L:108-214 | CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18 |
| 4H88 | L:108-213 | STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120-230 |
| 4HC1 | L:108-213; N:108-213 | CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3 |
| 4HDI | A:113-217; L:113-219 | CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS |
| 4HLZ | H:110-213; J:110-214; L:110-214 | CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ |
| 4HXA | L:108-214 | CRYSTAL STRUCTURE OF 13D9 FAB |
| 4HXB | L:108-214 | CRYSTAL STRUCTURE OF 6B9 FAB |
| 4I9W | D:107-211; F:107-211 | HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE |
| 4IRS | A:186-279; C:115-203; D:113-240 | STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX |
| 4J1U | A:113-214; C:113-216; E:113-216 | CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT |
| 4JN1 | L:114-220 | AN ANTIDOTE FOR DABIGATRAN |
| 4JN2 | A:114-220; L:114-220 | AN ANTIDOTE FOR DABIGATRAN |
| 4JQI | L:109-190 | STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE |
| 4JR9 | L:107-211 | CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK |
| 4JRE | C:107-211; L:107-211 | CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND |
| 4JZJ | B:114-219; L:114-219 | CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX |
| 4K23 | L:108-213 | STRUCTURE OF ANTI-UPAR FAB ATN-658 |
| 4K7P | L:108-214 | GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG |
| 4K9E | L:111-227 | CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D |
| 4KI5 | F:108-214 | CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99 |
| 4KJW | D:107-211; F:107-211 | STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE |
| 4KK5 | D:107-211; F:107-211 | STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE |
| 4KK6 | D:107-211; F:107-211 | STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE |
| 4KK9 | D:107-211; F:107-211 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE |
| 4KKA | D:107-211; F:107-211 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE |
| 4KKB | D:107-211; F:107-211 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE |
| 4KKC | D:107-211; F:107-211 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE |
| 4KPH | L:108-212; M:108-210 | STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN |
| 4KQ4 | L:108-214 | CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357 |
| 4KRP | C:108-211 | NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR |
| 4KUZ | L:113-216 | CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM |
| 4KVC | L:108-212 | 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS |
| 4LEO | B:114-219 | CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3) |
| 4LEX | L:113-217 | UNLIGANDED CRYSTAL STRUCTURE OF MAB7 |
| 4LF3 | A:107-214; D:107-214 | INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR |
| 4LVH | C:111-210; F:111-210; I:111-210; L:111-210 | INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ |
| 4M43 | L:108-213 | CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11 |
| 4M61 | A:113-219; C:113-219 | CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52 |
| 4M7J | L:108-214 | CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE |
| 4M7K | L:114-220 | CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10 |
| 4M7Z | C:108-214; L:108-213 | UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB |
| 4M93 | C:108-213; L:108-213 | UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB |
| 4MA1 | C:108-214; F:108-214; L:108-214 | UNLIGANDED 3 CRYSTAL STRUCTURE OF S25-26 FAB |
| 4MA7 | L:108-213 | CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE |
| 4MA8 | L:108-213 | CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE |
| 4MAU | L:112-216 | CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244 |
| 4NCC | 1:107-210; L:107-211 | NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS |
)
)